As of Tuesday, December 30, Ultragenyx Pharmaceutical Inc.’s RARE share price has surged by 9.99%, which has investors questioning if this is right time to sell.

This Research Topic invites high-impact research that advances nanotechnology-enabled antiviral interventions across the pipeline from molecular design to ...

Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's ...

Experiments conducted in genetically engineered mice reinforce that CSE protein (ordinarily known for producing hydrogen ...

Who is a certified cognitive behavioral therapist? Many therapists practice cognitive behavioral therapy. There is no certification or license required to become a cognitive behavioral therapist, but ...